Saiya Gene X Jikang, Taiwan Province, teamed up to build a personalized genetic testing service brand.
In 2008, the "Saiya Gene 200/KLOC-0" cocktail party was established. The whole genome scanning chip was publicly presented at the China Gene Database. In 2008, it appeared on the cover of the Singaporean magazine Biospectrum. In March 2000/KLOC-0, the Saiya Gene Laboratory was established, focusing on the human genome. Committed to the association research between disease and single nucleotide polymorphism (SNP * * *), engaged in pharmacogenomics research and clinical application development, and completed a number of drug efficacy and gene correlation analysis products and disease gene function research results over the years. There are two international standard certification laboratories (TAFISO 17025) in Taipei and Shanghai, and the accuracy of gene analysis is over 99.9%. The experimental and test data issued by them are very popular in 38 advanced countries on five continents. It has also established a close cooperation network with major research centers and medical institutions in Asia, and accumulated rich Asian genome research and development resources. It not only integrates the frontier core technology platform of genome research, but also establishes a complete clinical research service experience of drug genome in different stages of drug research and development. It is a partner of European and American biotechnology companies and multinational pharmaceutical companies in drug genome research and development in Asia. Under the leadership of Dr. Chen, the chief consultant scientist of the gene decoding project, Saiya Gene established the world's only China Genome Information Center, and developed the world's first "whole genome scanning chip" dedicated to China people, which was used to screen the special genetic variations in China population, find out the significance of these genetic variations, and further applied to the development of gene molecular diagnosis and personalized genetic testing.
Saiya Genetic Laboratory has accumulated rich R&D strength and intellectual property rights, filed 13 patent applications, obtained 5 patents from the United States, China and Taiwan Province, and published more than 60 foreign papers and periodicals, which has a profound scientific theoretical foundation and R&D energy. In 2006, Saiya Gene won the Outstanding Innovative Enterprise Award, the Top Ten Potential Enterprises of the Republic of China and the Top Ten Potential Golden Torch Award of the Ministry of Economic Affairs 14 Industrial Science and Technology Development Award respectively. In 2006, it was awarded the top ten influential life science companies in Asia and the most explosive biotechnology company in the Asia-Pacific region in 20 10 by BioSpectrum, a well-known biotechnology magazine in Singapore. It is the only biotechnology company in Taiwan Province Province.
On August 20 10, we further cooperated with the Affiliated Hospital of Taipei Medical College in the research and practice of clinical genome analysis, and established the first "Gene Sequencing Center" in Taiwan Province Province with the medical team of Qiu, Vice President of Hematology Oncology Department, to provide personalized genetic physique information for clinicians and cancer patients, so as to choose the most effective, accurate and least side-effect course of medication when using chemotherapy and targeted drugs. So far, more than 100 people have done this. .
TAF:ISO 17025 molecular laboratory certification is the first private certification laboratory in Taiwan Province Province.
The high-performance gene sequencer of Isaiah Gene Core Equipment Laboratory is located in the Gene Sequencing Center of the Affiliated Hospital of ABI Taipei Medical College -3500 DX, and the laboratory staff conducts gene sequencing analysis. In 2005, TAF:ISO 17025 molecular laboratory was certified as the first private certification laboratory in Taiwan Province Province, aiming at the unique base of China people. Due to variation, the information of Asian Chinese gene database accumulated for more than ten years is integrated. In recent two years, in cooperation with Jikang, Taiwan Province Province, a series of personalized gene detection kits have been successfully developed. Only a small number of oral mucosal cells are collected for DNA gene analysis, and many major disease risks, including cancer, cardiovascular and cerebrovascular diseases, type II diabetes, Alzheimer's disease (Alzheimer's disease) and Parkinson's disease, can be analyzed, so that subjects can do health management as soon as possible and avoid the occurrence of diseases. .
"Personalized genetic testing" package service jointly developed by Saiya Gene and Ji Kang, Taiwan Province Province.
The purpose of personalized genetic testing is to let us know our genetic risk composition. Before becoming a "sub-health group", let's make early prevention and plan health management strategies for high-risk diseases, so as to maintain a youthful and healthy state for a long time, not only live for a long time, but also live with quality. Personalized genetic testing has become an indispensable key to preventive medicine. Domestic large-scale medical and health examination units have combined health care with genetic testing one after another, allowing professional doctors to tailor their own health management strategies according to their clients' innate physique, and gradually realize the ideal of "personalized medical care".
Topic: Kikang, Taiwan Province Province, genetic testing, and the gene of Saiya.